Profile
EVAX VRTX REGN SGEN ALNY ARGX
Company Name Evaxion Biotech A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $533.75K $130.72B $61.65B $43.15B $35.25B $34.28B
Employees 0.05K 6.10K 15.11K 3.26K 2.23K 1.60K
CEO Mr. Christian Kanstrup M.Sc. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
EVAX VRTX REGN SGEN ALNY ARGX
Quant Rating Score 1 2 4 3 1 3
Quant Rating Strong Sell Sell Buy Neutral Strong Sell Neutral
Trading
EVAX VRTX REGN SGEN ALNY ARGX
Last Close $1.35 $475.49 $546.39 $228.74 $226.28 $546.22
High 52 $6.03 $516.74 $1201.76 $228.74 $296.75 $671.75
Low 52 $0.85 $392.81 $546.39 $228.74 $143.31 $356.01
Price vs. 52 Week High -77.61 % -7.98 % -54.53 % 0 % -23.75 % -18.69 %
Price vs. 52 Week Low 58.82 % 21.05 % 0 % 0 % 57.9 % 53.43 %
Total Return
EVAX VRTX REGN SGEN ALNY ARGX
1 Month Return -28.95 % -2.63 % -23.84 % 0 % -5.23 % -6.01 %
3 Month Return 50 % 16.1 % -21.59 % 0 % -4.92 % -16.77 %
6 Month Return -48.08 % -1.29 % -46.2 % 0 % -20.41 % 1.77 %
9 Month Return -57.81 % -3.38 % -49.42 % 0 % -13.31 % 18.3 %
YTD Return 59.69 % 18.08 % -23.3 % 0 % -3.84 % -11.18 %
1 Year Return -65.3 % 18.8 % -40.63 % 0 % 48.78 % 43.87 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
EVAX VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -2007 % -1.65 % 5.37 % -2.27 % -0.24 % -44.32 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Growth
EVAX VRTX REGN SGEN ALNY ARGX
Asset Growth 121.87 % -0.87 % 14.15 % -1.21 % 10.71 %
Gross Profit Growth 112.76 % 10.25 % 8.23 % 22.93 % 26.81 %
Revenue Growth - 11.66 % 8.27 % 24.65 % 22.97 %
Revenue 3 Year - 45.6 % -13.44 % 91.56 % 145.29 %
Revenue 5 Year - 163.93 % 82.78 % 215.48 % 769.33 %
Revenue 10 Year - 1632.15 % 429.43 % 494.04 % 2468.51 %
EBIT Growth 12.14 % -105.41 % -1.39 % 10.13 % 37.31 %
Net Income Growth 4.51 % -114.8 % 11.61 % 9.51 % 36.82 %
Net Income 3 Yeari Growth Per Share 12.7 % -122.89 % -46.47 % -763.59 % 69.96 %
Net Income 5 Yeari Growth Per Share -180.74 % -145.38 % 111.07 % -276.93 % 73.33 %
Net Income 10 Yeari Growth Per Share - 33.84 % 1232.49 % -624.16 % 55.42 %
Operating Income Growth 12.14 % -105.41 % -1.39 % 10.13 % 37.31 %
Operating Cash Flow Growth (CFG) 31.36 % -113.93 % -3.78 % 9.07 % -107.98 %
Operating 3 Year CFG 15.72 % -118.65 % -38.85 % -147.99 % 98.81 %
Operating 5 Year CFG -524.05 % -131.3 % 84.11 % -195.86 % 97.46 %
Operating 10 Year CFG - 12.43 % 517.51 % -2622.09 % 97.1 %
EPS Growth 17.24 % -114.8 % 10.39 % 10.81 % 38.64 %
EPS Diluted Growth 17.24 % -114.97 % 10.27 % 10.81 % 38.64 %
Book Value Per Share 94.37 % -6.59 % 11.76 % -9.83 % 129.53 %
Share Holder 3 Year Equity Growth Per Share -139.82 % 62.6 % 53.21 % 33.72 % -89.49 %
Share Holder 5 Year Equity Growth Per Share -256.75 % 168.85 % 167.88 % 220.81 % -96.04 %
Share Holder 10 Year Equity Growth Per Share - 1265.7 % 1113.59 % 691.19 % -95.86 %
Dividend Per Share Growth - - - - -
Dividend 3 Year Growth Per Share - - - - -
Dividend 5 Year Growth Per Share - - - - -
Dividend 10 Year Growth Per Share - - - - -
Debt Growth 382.04 % 116.42 % 0.06 % -23.28 % -51.69 %
Free Cash Flow Growth 31.8 % -124.1 % -0.08 % 3.67 % -201.54 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
EVAX VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 100 % 86.09 % 84.47 % 72.37 % 85.62 % 46.33 %
Return on Assets TTM -75.74 % -2.38 % 11.69 % -11.76 % -6.56 % 13.45 %
Return on Equity TTM 5765.59 % -3.28 % 14.77 % -16.53 % 905.33 % 16.83 %
Return on Capital Employed TTM -99.44 % -1.3 % 10.89 % -16.87 % -5.79 % -0.31 %
Net Income Per EBT TTM 94.31 % -215.53 % 92.32 % 100.55 % 73.71 % 25990.14 %
EBT Per Ebit TTM 80.76 % -100.69 % 118.85 % 94.01 % 213.34 % -18.79 %
EBIT Per Revenue TTM -456.89 % -2.24 % 28.32 % -36.09 % -7.87 % -0.77 %
Cash Flow To Debt Ratio TTM - -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Receivables Turnover TTM - 6.84 2.29 1.98 5.55 2.46
Payables Turnover TTM - 3.71 2.79 1.54 3.66 1.83
Inventory Turnover TTM - 1.27 0.71 0.65 4.12 2.93
Fixed Asset Turnover TTM - 425.82 % 308.76 % 256.83 % 323.99 % 5106.8 %
Asset Turnover TTM 21.76 % 48.84 % 37.61 % 34.46 % 53.02 % 35.83 %
Operating Cash Flow Per Share TTM -0.07 -1.91 41.08 -1.12 -0.06 -1.07
Free Cash Flow Per Share TTM -0.07 -3.07 33.43 -1.62 -0.33 -1.09
Cash Per Share TTM 16.56 % 2375.11 % 16647.4 % 657.5 % 2095.42 % 4597.04 %
Operating Cash Flow Sales Ratio TTM -60.73 % -4.48 % 31.13 % -16.85 % -0.37 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.95 % 160.43 % 81.38 % 144.14 % 512.38 % 102.26 %
Cash Flow Coverage Ratios TTM - -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.27 -165.4 17.14 -141.85 -827.74 -444.85
Price To Operating Cash Flows Ratio TTM -1.16 -266.09 13.96 -203.89 -4192.79 -531.16
Price Cash Flow Ratio TTM -1.16 -266.09 13.96 -203.89 -4192.79 -531.16
Income Statement (TTM)
EVAX VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.62B $-0.18B $0B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -10 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
EVAX VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.01B $1.66B $2.7B $0.04B $0B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $0.87B $4.17B $0.68B
Total Equity $-0B $16.41B $29.35B $2.8B $0.07B $5.31B
Total Investments $0B $6.65B $6.52B $1.42B $1.73B $1.82B
Total Debt $0.01B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.01B $22.53B $37.76B $3.67B $4.24B $5.99B
Cash Flow Statement (TTM)
EVAX VRTX REGN SGEN ALNY ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.8B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 18.7
ABCL AbCellera Biologics Inc. 2.405
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.605
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.11
ABPWW 0.0418
ABSI Absci Corporation 3.01
ABUS Arbutus Biopharma Corporation 3.14
ABVC ABVC BioPharma, Inc. 0.914
ABVX Abivax SA American Depositary Shares 5.972
ACAD ACADIA Pharmaceuticals Inc. 14.561
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.5332
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.18
ACIU AC Immune SA 1.56
ACLX Arcellx, Inc. 59.09
Unlock